Walleye Capital’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
34,267
+2,983
| +10% | +$195K | 0.01% | 593 |
|
|
2025
Q1 | $2.09M | Sell |
31,284
-40,725
| -57% | -$2.73M | 0.01% | 585 |
|
|
2024
Q4 | $3.98M | Buy |
+72,009
| New | +$3.98M | 0.01% | 500 |
|
|
2024
Q3 | – | Sell |
-10,849
| Closed | -$691K | – | 2463 |
|
|
2024
Q2 | $691K | Buy |
+10,849
| New | +$691K | ﹤0.01% | 1298 |
|
|
2023
Q4 | – | Sell |
-8,489
| Closed | -$493K | – | 2169 |
|
|
2023
Q3 | $493K | Buy |
+8,489
| New | +$493K | ﹤0.01% | 1155 |
|
|
2020
Q3 | – | Sell |
-9,235
| Closed | -$299K | – | 808 |
|
|
2020
Q2 | $299K | Buy |
+9,235
| New | +$299K | 0.07% | 335 |
|
|
2020
Q1 | – | Sell |
-239
| Closed | -$15K | – | 524 |
|
|
2019
Q4 | $15K | Sell |
239
-10,663
| -98% | -$669K | ﹤0.01% | 579 |
|
|
2019
Q3 | $794K | Buy |
10,902
+7,246
| +198% | +$528K | 0.05% | 61 |
|
|
2019
Q2 | $301K | Buy |
3,656
+3,036
| +490% | +$250K | 0.03% | 80 |
|
|
2019
Q1 | $44K | Buy |
+620
| New | +$44K | 0.01% | 246 |
|